Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions

Leukemia and Lymphoma

Volumn 49, Issue 8, 2008, Pages 1553-1559

  Parasole, Rosanna ^a   Menna, Giuseppe ^a   Marra, Nicoletta ^a   Petruzziello, Fara ^a   Locatelli, Franco ^b   Mangione, Argia ^a   Misuraca, Aldo ^a   Buffardi, Salvatore ^a   Di Cesare Merlone, Alessandra ^b   Poggi, Vincenzo ^a  

^a SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chemotherapeutic approaches; CNS relapse; Intrathecal liposomal cytarabine; Neoplasia; Pediatric acute lymphoblastic leukemia

Indexed keywords

ASPARAGINASE; CARBOPLATIN; CORTICOSTEROID; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; NELARABINE; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASTHENIA; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPERIENCE; FEMALE; HEADACHE; HUMAN; LEUKEMIA RELAPSE; LEUKEMIC MENINGITIS; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NEUROTOXICITY; PEDIATRICS; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; CYTARABINE; DRUG CARRIERS; DRUG EVALUATION; FEMALE; HUMANS; INFANT; INJECTIONS, SPINAL; LIPOSOMES; MALE; MENINGEAL NEOPLASMS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; TREATMENT OUTCOME;

EID: 51349152996     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802216749     Document Type: Article

References (21)

1. Pui, C-H and Horward, S. C. (2008) Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol, 9, pp. 257-268.
2. Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H. Thyss, A. et al. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukaemia: A CLCG-EORTC report. Leukemia, 14, pp. 2257-2266.
3. Pui, C-H (2003) Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukaemia. J Clin Oncol, 21, pp. 179-181.
4. Burger, B., Zimmermann, M., Mann, G., Kuhl, J., Loning, L. Riehm, H. et al. (2003) Diagnostic cerebrospinal fluid (CSF) examination in children with acute lymphoblastic leukemia (ALL): Significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol, 21, pp. 184-188.
5. Conter, V., Schrappe, M., Arico, M., Reiter, A., Dordelmann, M. Valsecchi, M. G. et al. (1997) Role of cranial radiotherapy for childhood T-cell lymphoblastic leukaemia with high WBC count and good response to prednisone. J Clin Oncol, 15, pp. 2786-2791.
6. Murry, D. J. and Blaney, S. M. (2000) Clinical pharmacology of endocapsulated sustained-release cytarabine. Ann Pharmacother, 34, pp. 1173-1178.
7. Bomgaars, L., Geyer, J. R., Franklin, J., Dahl, G., Park, J. Winick, N. J. et al. (2004) Phase I trial of intrathecal liposomal Cytarabine in children with neoplastic meningitis. J Clin Oncol, 22, pp. 3916-3921.
8. Sancho, J. M., Ribera, J. M., Romero, M. J., Martin-Reina, V., Giraldo, Pilar and Ruiz, E. (2006) Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukaemia: Report of 6 cases. Haematologica, 91, pp. e3-e5.
9. Jabbour, E., O'Brien, S., Kantarjian, H., Garcia-Manero, G., Ferrajoli, A. Ravandi, F. et al. (2007) Neurological complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphoblastic leukaemia. Blood, 109, pp. 3214-3218.
10. Chamberlain, M. C. and Glantz, M. J. (2007) Neurological complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphoblastic leukaemia. Blood, 110, p. 1698.
11. Pui, C-H (2007) Toward optimal use of intrathecal liposomal cytarabine. Leuk Lymphoma, 48, pp. 1672-1673.
12. McClune, B., Buadi, F. K., Aslam, N. and Przepiorka, D. (2007) Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphoblastic leukaemia and high-grade lymphoma. Leuk Lymphoma, 48, pp. 1849-1851.
13. Benesch, M., Sovinz, P., Krammer, B., Lackner, H., Mann, G. Schwinger, W. et al. (2007) Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. J Pediatr Hematol Oncol, 26, pp. 222-226.
14. National Cancer Institute (1988) Guidelines for Reporting of Adverse Drugs Reactions, Divisions of Cancer Treatment, National Cancer Institute, Bethesda, MD
15. Flohr, T., Scrauder, A., Cazzaniga, G., Panzer-Grumayer, R., van der Velden, V. Fisher, S. et al. (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22, pp. 771-782.
16. Arico, M., Valsecchi, M. G., Rizzari, C., Barisone, E., Biondi, A. Casale, F. et al. (2008) Long-term results of the AIEOP-ALL-95 trial for childhood acute lymphoblastic leukemia: Insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster-based chemotherapy. J Clin Oncol, 26, pp. 283-289.
17. Uderzo, C., Conter, V., Dini, G., Locatelli, F., Miniero, R. and Tamaro, P. (2001) Treatment of childhood acute lymphoblastic leukemia after the first relapse: Curative strategies. Haematologica, 86, pp. 1-7.
18. Rivera, G. K., Hudson, M. M., Liu, Q., Benaim, E., Ribeiro, R. C. Crist, W. M. et al. (1996) Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia. Blood, 88, pp. 831-837.
19. Ochs, J. J., Rivera, G., Aur, R. J., Hustu, H. O., Berg, R. and Simone, J. V. (1985) Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia. J Clin Oncol, 3, pp. 622-626.
20. Vezmar, S., Becker, A., Bode, U. and Jaehde, U. (2003) Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy, 49, pp. 92-104.
21. Resar, L. M., Phillips, P. C., Kastan, M. B., Leventhal, B. G., Bowman, P. W. and Civin, C. I. (1993) Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukaemia of B-cell type. Cancer, 71, pp. 117-123.